ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

9.67

-0.47 (-4.64%)

At close: Feb 5, 2026, 4:00 PM EST

9.55

-0.12 (-1.24%)

After-hours: Feb 5, 2026, 7:15 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Needle-free Intranasal	30.00K
Needle-free Intranasal Growth	-97.72%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.